Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Pick Your #1 Kind Of Treat - 2How Trump's marijuana executive order could change medical research landscape
- 3Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- 4Manual for 6 famous sorts of cheddar
- 5'Spending more on gas than groceries:' Rising fuel prices drive more San Antonio families to the Food Bank amid Iran war
- Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix
- Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
- Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- Explosions heard across Tehran after IDF announces wave of strikes on regime terror targets
- Make your choice for the music application with the most amicable connection point!
- Coffee Prices Finish Higher on Brazil Cop Concerns
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Novo Nordisk gears up for December Ozempic launch in India, sources say
